UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Medical Innovation And The Changing Health And Health Care Costs Of Obesity

Value in health, 2014-05, Vol.17 (3), p.A110-A111

2014

Volltextzugriff (PDF)

Construct validity of the SF-12 in type-1 diabetes

Value in health, 2013-05, Vol.16 (3), p.A32-A32

2013

Volltextzugriff (PDF)

PIH24 Modeling the Health and Medical Care Spending of the Future Elderly: An Update Using the Future Elderly Model

Value in health, 2012-06, Vol.15 (4), p.A195-A196

2012

Volltextzugriff (PDF)

PHP40 Hospital Spending and Inpatient Mortality

Value in health, 2012-06, Vol.15 (4), p.A20-A20

2012

Volltextzugriff (PDF)

PCSK9 INHIBITORS SHOW VALUE FOR PATIENTS AND THE U.S. HEALTHCARE SYSTEM

Value in health, 2017-05, Vol.20 (5), p.A269

2017

Volltextzugriff (PDF)

SOCIOECONOMIC DISPARITIES IN MEDICATION ADHERENCE AMONG PRIVATELY INSURED PATIENTS IN THE UNITED STATES

Value in health, 2017-05, Vol.20 (5), p.A57

2017

Volltextzugriff (PDF)

PDB81 - Estimating the Effects of Extended-Release Formulations on Adherence, HBA1C Control and Hospital Outcomes

Value in health, 2018-05, Vol.21, p.S79-S79

2018

Volltextzugriff (PDF)

Estimating the Effects of Extended-Release Formulations on Adherence, HBA1C Control and Hospital Outcomes

Value in health, 2018-05, Vol.21, p.S79

2018

Volltextzugriff (PDF)

PCV51 - Medical Innovation And The Changing Health And Health Care Costs Of Obesity

Value in health, 2014-05, Vol.17 (3), p.A110-A111

2014

Volltextzugriff (PDF)

CE3 - First-Line Pembrolizumab in PD-L1 Positive Non-Small Cell Lung Cancer: A Cost-Effectiveness Analysis from A UK Healthcare Perspective

Value in health, 2017-10, Vol.20 (9), p.A399-A399

2017

Volltextzugriff (PDF)

First-Line Pembrolizumab in PD-L1 Positive Non-Small Cell Lung Cancer: A Cost-Effectiveness Analysis from A UK Healthcare Perspective

Value in health, 2017-10, Vol.20 (9), p.A399

2017

Volltextzugriff (PDF)

PRM108 - Construct validity of the SF-12 in type-1 diabetes

Value in health, 2013-05, Vol.16 (3), p.A32-A32

2013

Volltextzugriff (PDF)

PSY117 - Do Commercial Health Care Prices Influence Medicare Spending?

Value in health, 2018-05, Vol.21, p.S263-S263

2018

Volltextzugriff (PDF)

PCV74 - Three-Part Pricing to Reward Pharmaceutical Innovation and Increase Access: Case of PCSK9 Inhibitors

Value in health, 2018-05, Vol.21, p.S65-S65

2018

Volltextzugriff (PDF)

Impact of Medicaid Treatment Access Policies on the Hepatitis C Epidemic

Value in health, 2018-05, Vol.21, p.S87

2018

Volltextzugriff (PDF)

Three-Part Pricing to Reward Pharmaceutical Innovation and Increase Access: Case of PCSK9 Inhibitors

Value in health, 2018-05, Vol.21, p.S65

2018

Volltextzugriff (PDF)

Do Commercial Health Care Prices Influence Medicare Spending?

Value in health, 2018-05, Vol.21, p.S263

2018

Volltextzugriff (PDF)

Trends in the Economic Value of Newly Approved Cancer Therapies in the U.S

Value in health, 2018-05, Vol.21, p.S3

2018

Volltextzugriff (PDF)

PGI33 - Impact of Medicaid Treatment Access Policies on the Hepatitis C Epidemic

Value in health, 2018-05, Vol.21, p.S87-S87

2018

Volltextzugriff (PDF)

VA2 - Trends in the Economic Value of Newly Approved Cancer Therapies in the U.S

Value in health, 2018-05, Vol.21, p.S3-S3

2018

Volltextzugriff (PDF)

PCN196 - The Long-Term Social Value Of Better Targeting G-Csf Therapy To Cancer Patients At Risk Of Febrile Neutropenia

Value in health, 2018-05, Vol.21, p.S42-S43

2018

Volltextzugriff (PDF)

The Long-Term Social Value Of Better Targeting G-Csf Therapy To Cancer Patients At Risk Of Febrile Neutropenia

Value in health, 2018-05, Vol.21, p.S42-S43

2018

Volltextzugriff (PDF)

PCN92 THE WAR ON CANCER: AN ECONOMIC EVALUATION OF RECENT GAINS IN CANCER SURVIVAL

Value in health, 2008, Vol.11 (3), p.A82-A82

2008

Volltextzugriff (PDF)

PND37 PROJECTING THE BURDEN OF ALZHEIMER'S DISEASE AND EVALUATING THE POTENTIAL IMPACTS OF PREVENTING ALZHEIMER'S DISEASE IN THE UNITED STATES

Value in health, 2010, Vol.13 (3), p.A144-A144

2010

Volltextzugriff (PDF)

The Health Value and Cost of Care for Major Depression

Value in health, 2009, Vol.12 (1), p.65-72

2009

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Aktive Filter

KollektionSingle Journals

SpracheJapanisch

KollektionIngenta

Zeitschrift / SerieValue In Health

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)

Erscheinungsjahr

n.n

Thema

Internal Medicine
(9)
Cost Analysis
(2)
Health Care Expenditures
(2)
Life Expectancy
(2)
Life Span
(2)
Patients
(2)
Adherence
(1)
Adolescent
(1)
Adult
(1)
Antidepressant Drugs
(1)
Antidepressive Agents - Economics
(1)
Antidepressive Agents - Therapeutic Use
(1)
Antidiabetics
(1)
Antihypertensives
(1)
Arteriosclerosis
(1)
Atherosclerosis
(1)
Beneficiaries
(1)
Business & Economics
(1)
Cardiovascular Disease
(1)
Cardiovascular Diseases
(1)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Medical Innovation And The Changing Health And Health Care Costs Of Obesity

Construct validity of the SF-12 in type-1 diabetes

PIH24 Modeling the Health and Medical Care Spending of the Future Elderly: An Update Using the Future Elderly Model

PHP40 Hospital Spending and Inpatient Mortality

PCSK9 INHIBITORS SHOW VALUE FOR PATIENTS AND THE U.S. HEALTHCARE SYSTEM

SOCIOECONOMIC DISPARITIES IN MEDICATION ADHERENCE AMONG PRIVATELY INSURED PATIENTS IN THE UNITED STATES

PDB81 - Estimating the Effects of Extended-Release Formulations on Adherence, HBA1C Control and Hospital Outcomes

Estimating the Effects of Extended-Release Formulations on Adherence, HBA1C Control and Hospital Outcomes

PCV51 - Medical Innovation And The Changing Health And Health Care Costs Of Obesity

CE3 - First-Line Pembrolizumab in PD-L1 Positive Non-Small Cell Lung Cancer: A Cost-Effectiveness Analysis from A UK Healthcare Perspective

First-Line Pembrolizumab in PD-L1 Positive Non-Small Cell Lung Cancer: A Cost-Effectiveness Analysis from A UK Healthcare Perspective

PRM108 - Construct validity of the SF-12 in type-1 diabetes

PSY117 - Do Commercial Health Care Prices Influence Medicare Spending?

PCV74 - Three-Part Pricing to Reward Pharmaceutical Innovation and Increase Access: Case of PCSK9 Inhibitors

Impact of Medicaid Treatment Access Policies on the Hepatitis C Epidemic

Three-Part Pricing to Reward Pharmaceutical Innovation and Increase Access: Case of PCSK9 Inhibitors

Do Commercial Health Care Prices Influence Medicare Spending?

Trends in the Economic Value of Newly Approved Cancer Therapies in the U.S

PGI33 - Impact of Medicaid Treatment Access Policies on the Hepatitis C Epidemic

VA2 - Trends in the Economic Value of Newly Approved Cancer Therapies in the U.S

PCN196 - The Long-Term Social Value Of Better Targeting G-Csf Therapy To Cancer Patients At Risk Of Febrile Neutropenia

The Long-Term Social Value Of Better Targeting G-Csf Therapy To Cancer Patients At Risk Of Febrile Neutropenia

PCN92 THE WAR ON CANCER: AN ECONOMIC EVALUATION OF RECENT GAINS IN CANCER SURVIVAL

PND37 PROJECTING THE BURDEN OF ALZHEIMER'S DISEASE AND EVALUATING THE POTENTIAL IMPACTS OF PREVENTING ALZHEIMER'S DISEASE IN THE UNITED STATES

The Health Value and Cost of Care for Major Depression

Aktive Filter

Suchergebnisse filtern